GX-19: Clinical Trials

1 trial of GX-19, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Terminated 1
Phase 21Terminated 1

Follow GX-19: new trials by email Literature Review of GX-19 trials Research Report on GX-19

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety and Immunogenicity Study of GX-19, a COVID-19 Preventive DNA Vaccine in Healthy Adults
GX-19, Saline - SARS-CoV-2
Phase 1 / Phase 2TerminatedGenexine, Inc.602020-06-172025-08-20

Sponsors

Genexine, Inc. (1)

Countries

South Korea (1)

Top investigators

JungWon Woo, Ph.D. (1)